Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2693_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
38 Мб
Скачать
21 Cyanide Poisoning

Factors That Exclude Diagnosis

• There is no clinical exclusion for cyanide poisoning when the presentation is suggestive.

Ancillary Studies

Laboratory

• Basic metabolic panel to assess for anion gap metabolic acidosis
• Serum lactate:
• Closely correlates with severity of cyanide toxicity
• A normal level casts doubt on true cyanide poisoning.
• Levels may be used to monitor treatment progress.
• Central venous blood gas to assess venous arterial PO2 gradient
• Carboxyhemoglobin and methemoglobin levels in concomitant carbon mon­oxide exposure
• Cyanide levels:
323
• May be obtained for diagnostic conrmation, but results will not be avail-
able in time to be clinically useful and may be unreliable
• Levels do not correlate directly with survivability.

Special Populations

Age
• Sodium nitrite–induced 20–30 % level of methemoglobinemia may be lethal in children or anemic patients and should not be given to pregnant patients.
• Pediatric patients are thought to be vulnerable to cyanide exposure because of their higher respiratory rates and immature detoxication systems.

Co-morbidities

• Patients with limited cardiopulmonary reserve who are exposed to cyanide have a poorer prognosis.
324
C. V. Pollack, Jr. et al.

Pregnancy

• Fetal demise is possible in cyanide poisoning. Aggressive support and anti­dotal treatment of the mother are essential.
Pitfalls inDiagnosis
Critical Steps Not toMiss
• The presentation of carbon monoxide poisoning from smoke inhalation is similar to that of cyanide poisoning; thus, clinicians often focus on carboxy­hemoglobin levels, neglecting coexistent cyanide toxicity.

Mimics

• Mimics of cyanide poisoning include those listed as differential consider­ations, especially
• Carbon monoxide poisoning
• Phosgene exposure
• Hydrogen sulde poisoning
• Arsine exposure
• Inert gas exposure

Time-Dependent Interventions

• If clinical history and exam suggest cyanide poisoning, antidotal therapy must be given immediately.
Overall Principles ofTreatment
• Decontaminate as soon as possible, removing patient from cyanide source.
• Rescuers should wear protective suits and respirators until proper decon-
tamination is complete.
• Antidotal treatment involves three strategies: binding of cyanide, use of sulfur donors, and induction of methemoglobinemia.
• Hydroxocobalamin, a precursor of vitamin B
that avidly binds to intracellular cyanide, forming cyanocobalamin.
, contains a cobalt moiety
12
21 Cyanide Poisoning
• Cyanocobalamin is excreted in urine.
• Sodium thiosulfate
• Sulfur donor excreted renally
• +/− Sodium nitrite
• Induces methemoglobinemia, with the goal of a 20–30 % methemoglobin
level if tolerated
• It is CONTRAINDICATED in cases of potential carbon monoxide
toxicity.
• May cause hypotension and tachycardia, vasodilation

Disease Course

• Prognosis depends on level of exposure and extent of symptoms at presentation.
• Even in patients with severe symptoms such as seizures at presentation, prompt administration of antidote improves prognosis.
• The exception is cardiac arrest, in which even early antidote administration
is unlikely to reverse the very poor prognosis.
325
• Patients who survive cyanide poisoning sometimes have long-term central nervous system complications, such as movement disorders and neuropsychi­atric problems.
• Suicide attempts with cyanide often are successful because of the deliberately high toxin load.

Related Evidence

Papers of particular interest have been highlighted as: ** Of key importance

Practice Guideline

Anseeuw K, Delvau N, Burillo-Putze G, De Iaco F, Geldner G, Holmström P,
Lambert Y, Sabbe M. Cyanide poisoning by re smoke inhalation: a European expert consensus. Eur J Emerg Med. 2013 Feb;20(1):2-9. https://doi.org/10.1097/
MEJ.0b013e328357170b. PMID: 22828651. http://www.ncbi.nlm.nih.gov/ pubmed/22828651 **
326
C. V. Pollack, Jr. et al.

Review

Huzar TF, George T, Cross JM.Carbon monoxide and cyanide toxicity: etiology,
pathophysiology and treatment in inhalation injury. Expert Rev Respir Med. 2013 Apr;7(2):159-70. https://doi.org/10.1586/ers.13.9. PMID: 23547992.
http://www.ncbi.nlm.nih.gov/pubmed/23547992 **
Dries DJ, Endorf FW.Inhalation injury: epidemiology, pathology, treatment strate-
gies. Scand J Trauma Resusc Emerg Med. 2013 Apr 19;21:31. https://doi.
org/10.1186/1757-7241-21-31. PMID: 23597126. http://www.ncbi.nlm.nih.gov/ pubmed/23597126 **
Reade MC, Davies SR, Morley PT, Dennett J, Jacobs IC; Australian Resuscitation
Council. Review article: management of cyanide poisoning. Emerg Med Australas. 2012 Jun;24(3):225-38. https://doi.org/10.1111/j.1742-6723.2012.01538.x. PMID: 22672162. http://www.ncbi.nlm.nih.gov/pubmed/22672162 **
O’Brien DJ, Walsh DW, Terriff CM, Hall AH.Empiric management of cyanide tox-
icity associated with smoke inhalation. Prehosp Disaster Med. 2011 Oct;26(5):374-
82. https://doi.org/10.1017/S1049023X11006625. PMID: 22336184. http://
www.ncbi.nlm.nih.gov/pubmed/22336184 **
Barillo DJ. Diagnosis and treatment of cyanide toxicity. J Burn Care Res. 2009
Jan-Feb;30(1):148-52. https://doi.org/10.1097/BCR.0b013e3181923b91. PMID:
19060738. http://www.ncbi.nlm.nih.gov/pubmed/19060738 **
Geller RJ, Barthold C, Saiers JA, Hall AH.Pediatric cyanide poisoning: causes, man-
ifestations, management, and unmet needs. Pediatrics. 2006 Nov;118(5):2146- 58. PMID: 17079589. http://www.ncbi.nlm.nih.gov/pubmed/17079589 **
Beasley DM, Glass WI.Cyanide poisoning: pathophysiology and treatment recom-
mendations. Occup Med (Lond). 1998 Oct;48(7):427-31. PMID: 10024740.
http://www.ncbi.nlm.nih.gov/pubmed/10024740 **
Use PubMed Clinical Queries to nd the most recent evidence. Use this search strategy: “Cyanide Poisoning” OR “Cyanide Toxicity”
Chapter 22
Cyanotic Congenital Heart Disease
RichardM.Cantor, CharlesV.Pollack,Jr., andJaimeFrielBlanck
Name andSynonyms
Cyanotic Congenital Heart Disease
• Refers to a subset of congenital cardiac malformations that favor the develop­ment of variable degrees of cyanosis.
• The vast majority of malformations will present in the newborn period and will be diagnosed in the neonatal setting.
• There are, however, variant forms which will “escape” neonatal diagnosis and have their initial cyanotic presentations in the Emergency Department.
• Late presentations are usually encountered in infants with ductus-dependent lesions necessary for pulmonary blood ow (generally left sided outow obstructions such as hypoplastic left ventricle or coarctation of the aorta).

Incidence/Epidemiology

• Fifteen to 20 percent of all congenital heart disease cases are of the cyanotic variety.
• Cyanotic forms account for nearly 30 percent of fatal cases.
R. M. Cantor Department of Emergency Medicine and Pediatrics, State University of NewYork Upstate Medical University, Syracuse, NY, USA
C. V. Pollack, Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA, USA
J. F. Blanck Welch Medical Library, Johns Hopkins University, Baltimore, MD, USA
C. V. Pollack, Jr. (ed.), Differential Diagnosis of Cardiopulmonary Disease,
https://doi.org/10.1007/978-3-319-63895-9_22
Jr. ()
327© Springer Nature Switzerland AG 2019
328
R. M. Cantor et al.

Differential Diagnosis

• Should be considered in the differential diagnosis of cyanotic congenital heart disease, often represented by the “5 T’s”:
• Truncus Arteriosus
• Transposition of the Great Arteries
• Tricuspid Atresia
• Tetralogy of Fallot
• Total Anomalous Pulmonary Venous Return
• There are other causes of cyanosis in young infants, most traditionally classi­ed into pulmonary insults and hemoglobinopathies (i.e., Methemoglobinemia)
Pathophysiology andEtiology
• The essential common pathway that serves as the basis for all congenital cya­notic cardiac lesions is an inability to deliver oxygen to the general circulation and therefore peripheral target organs.
• The predominant pathophysiology involves variable degrees of right-to-left shunting. Systemic (deoxygenated) blood is unable to access the alveoli, returning to the left side of the heart without being oxygenated. In most cases of cyanotic heart disease, the shunt is intracardiac.
Tetralogy of Fallot. (a, b) Tetralogy of Fallot, the most common cause of cyanotic congenital heart disease, consists of a membranous VSD right ventricular outow obstruction, rightward displacement of the aorta (AO), and secondary right ven­tricular hypertrophy. The right ventricular outow obstruction may take the form of hypoplasia of the pulmonary trunk (PT), pulmonary valvular malformation and ste­nosis, outow tract (infundibular) hypoplasia and narrowing, or a combination of all
22 Cyanotic Congenital Heart Disease
three components, as seen in this case [Buja LM, Cheong B. Cardiovascular Pathology. In: Krueger GRF, Buja LM, editors. Atlas of Anatomic Pathology with Imaging [Internet]. London: Springer London; 2013 [cited 2016 Jul 29]. p.43–104. Available from:
from original
http://link.springer.com/10.1007/978-1-4471-2846-5_2] Caption
329

Presentation

Typical/“Classic”

• Most entities will present within the rst few hours of life, with diagnosis made before discharge from the newborn unit.
• Other entities, specically those with ductal dependency, will only present when the duct closes. The infants will present with varying degrees of shock and/or cyanosis (usually left sided outow obstructive lesions such as an interrupted aortic arch).

Atypical

• Infants with Tetrology of Fallot may “escape” diagnosis in the rst few days of life, presenting to the ED with what are known as “Tet (hypercyanotic) Spells.”
• Management of Hypercyanotic Spells:
• Provision of supplemental oxygen.
• Placement in the knee chest position.
• Sedation with morphine (0.1 mg/kg/dose)
• Administration of 10-20 cc/kg of normal saline
• Immediate consultation with a pediatric cardiologist

Primary Differential Considerations

• These specic diagnoses should be considered in patients who present with signs and symptoms of congenital cyanotic heart disease:
• tricuspid atresia
• Ebstein’s malformation of the tricuspid valve
• severe pulmonic stenosis with intact ventricular septum
• complete transposition of the great vessels
• truncus arteriosus.
330
R. M. Cantor et al.
History andPhysical Exam
• As previously described, the majority of cyanotic congenital lesions will be diagnosed and treated within the rst few days of life.
• In some patients, cyanotic presentations may be quite dramatic, unresponsive to any degree of supplemental oxygen (the hyperoxia test).
• Other patients will present with hypoperfusion and frank hypotension. Administration of isotonic volume replacement will often worsen the clinical status, alerting the clinician to the possibility of a cardiogenic etiology as the cause of shock.
• Each particular malformation has a specic set of physical and radiographic ndings.
• The presence or absence of a murmur is variable and often not integral in making the diagnosis.
Clubbing. (a) The angle at the junction of skin with the nail at the dorsal surface of digits is normally around 160°. (b) In children with cyanotic congenital heart dis­eases this angle becomes wider and may exceed 180°. This is the result of hypoxia in peripheral tissue, which causes the opening of normally collapsed capillaries to better perfuse the hypoxic tissue. Perfusion of these collapsed capillaries will result in expansion of the volume of these peripheral tissues (tips of digits) resulting in clubbing. This phenomenon is seen in other lesions causing hypoxia of peripheral tissue, such as with chronic lung disease and chronic anemia (causing hypoxia through reduction of level of hemoglobin and therefore reduction of oxygen carry­ing capacity) such as with ulcerative colitis, Crohn’s disease, and chronic liver dis­ease [Thompson WR, Mehrotra SM.Cardiac History and Physical Examination. In: Abdulla R, editor. Heart Diseases in Children [Internet]. Boston, MA: Springer US; 2011 [cited 2016 Jul 29]. p. 3–16. Available from: http://link.springer.
com/10.1007/978-1-4419-7994-0_1
] Caption from original
Findings That Conrm Diagnosis
• Echocardiography remains the gold standard.
22 Cyanotic Congenital Heart Disease

Factors That Suggest Diagnosis

• The use of the hyperoxia test is traditionally employed to differentiate between pulmonary, cardiac, and hematologic causes of cyanosis in infancy.
• Administer supplemental oxygen.
• If OSAT rises, it is most likely pulmonary disease.
• If OSAT does not rise, consider Cyanotic Heart Disease or Methemoglo binemia.
• With the patient on 100% supplemental O
, and the pO2 is high and OSAT is
2
low, consider Methemoglobinemia as an etiology,
• With the patient on 100% supplemntalO2, and the pO2 is low and the OSAT is low, consider cyanotic heart disease as an etiology.

Factors That Exclude Diagnosis

• A normal echocardiogram.

Ancillary Studies

331

Imaging

• There are certain classic radiographic ndings associated with specic forms of cyanotic heart disease in infants:
• Cardiomegaly is seen with left-sided outow obstructive lesions.
• A boot-shaped heart is seen with Tetralogy.
• An “egg-on-a-string” pattern is seen with Transposition.
Utility of chest radiography in CHD.A: Chest radiograph of a neonate with d-trans­position of the great arteries, appearing as an “egg on a string” appearance of the
332
R. M. Cantor et al.
heart and mediastinum. This pattern-based approach to cardiac morphology is inac­curate and is rarely helpful for clinical management. Cardiac morphology is deter­mined by echocardiography in the neonatal period while the chest radiograph sheds light on physiology. B: Neonate with complex cyanotic congenital heart disease, including mitral atresia, total anomalous pulmonary venous connection to the coro­nary sinus, double outlet right ventricle, and pulmonary stenosis. The chest radio­graph demonstrated decreased pulmonary vascularity, which enabled decision- making regarding initial palliative treatment. The pulmonary blood ow was augmented using a modied Blalock–Taussig shunt. [Krishnamurthy R, Chitkara P.Evidence-Based Approach to Imaging of Congenital Heart Disease. In: Medina LS, Applegate KE, Blackmore CC, editors. Evidence-Based Imaging in Pediatrics [Internet]. NewYork, NY: Springer NewYork; 2010 [cited 2016 Jul 29]. p. 339–58. Available from: http://link.springer.com/10.1007/978-1-4419-0922-
0_24] Caption from original
A neonate with a congenital cyanotic heart disease born at 39 weeks. Maximum support and 100% oxygen did not lead to clinical improvement and the child died. T2-W coronal MRI shows a complete anomalous venous return (arrow) with pul­monary interstitial oedema (insert). A central tendon defect is seen (open arrow) (slice thickness: 2 mm, TR: 5500, TE: 54, FA: 180°). b T2-W coronal MRI shows a persistent left superior caval vein (arrow), a dextrocardia and situs intermedius of the liver. Asplenia was also noted [From article: Current techniques in postmortem imaging with specic attention to paediatric applications. Pediatric Radiology. 2010